Using the isoform-selective PI3Kβ inhibitor AZD6482 and the broad-spectrum MLK3 inhibitor URMC-099, concurrent inhibition of PI3Kβ and MLK3 showed synergistic inhibitory effects on the proliferation, migration and invasion of GBM cells. The gene discussed is MAP3K11; the disease is glioblastoma.